CA4 and cancer: Fosbretabulin (Zybrestat), a water-soluble version of CA-4 designed for better absorption, and Ombrabulin, a variant of CA-4 modified with serine, are both undergoing clinical trials of their effectiveness as independent cancer treatments as well as in combination with other chemotherapeutics or radiation therapy [18,19].